Laguna Hills-based medical device company making catheter-based neurovascular devices for stroke clot removal.
NeuroVasc Technologies designs catheter-based neurovascular devices, including the eNVi-SR, eNVoke and eNVac systems, for mechanical thrombectomy and aspiration to remove blood clots. It sells to hospitals and healthcare providers in more than 35 countries, typically per procedure or under bulk contracts. Founded in 2015 in Laguna Hills, US, the company raised USD 34 mn on February 27, 2020, led by Shandong Weigao Group Medical Polymer Co., Limited. Its CEO is Wanli Jiang.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in